Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2015

View Archived Issues

biOasis Technologies and Brigham and Women's Hospital form neuro-oncology R&D agreement

Lilly divulges several analyses of phase III solanezumab trial data

Allogeneic mesenchymal precursor cells show promising results for the treatment of type 2 diabetes

ASK-1 inhibition protects mice from thrombosis

Lpath receives FDA clearance to start phase I trial of Lpathomab

Lupin to acquire Gavis

Researchers publish preclinical data that led to advancement of antimalarial agent DSM-265

Bausch + Lomb submits Vesneo NDA

Zalviso recommended for approval in Europe

EMA committee grants accelerated assessment to ixazomib for relapsed/refractory multiple myeloma

FDA approves Odomzo for locally advanced BCC

Biohaven files IND for BHV-0223 for treatment-resistant affective disorders

Algomedix presents TRPA1 antagonists

Bristol-Myers Squibb patents ROR-gamma modulators

Blend Therapeutics divulges platinum complexes for cancer

Jiangsu Hansoh Pharmaceutical Group introduces NS5B inhibitors

Rhizen Pharmaceuticals patents glutaminase inhibitors

FDA approves Technivie for genotype 4 chronic HCV infection

Genentech to advance crenezumab into phase III for prodromal to mild Alzheimer's disease

EMA committee recommends approval of Fexeric

FDA approves Praluent to treat high LDL cholesterol

EMA committee recommends approval of Intuniv for ADHD in children and adolescents

FDA approves Daklinza for genotype 3 chronic HCV infection

Genzyme to acquire vandetanib from AstraZeneca

EMA Committee hands down positive opinion for Revolade in severe aplastic anemia

FDA approves Kyprolis in combination use for relapsed multiple myeloma

Omeros's OMS-721 receives fast track designation for aHUS

European recommendation, U.S. priority review for Tafinlar and Mekinist combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...